Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it

Abridge, a health tech startup, has partnered with NVIDIA and Eli Lilly to develop an AI-native clinician intelligence platform that streamlines clinical documentation, billing, and pharmaceutical trial screening. The platform, used by over 300 health systems, captures real-time patient-clinician conversations and has raised $1.1 billion, including a $316 million Series E extension. NVIDIA is co-developing a foundation model for clinical dialogue, while Eli Lilly aligns with its AI-driven healthcare initiatives.